Inhibition of the MLCK/MLC2 pathway protects against intestinal heat stroke-induced injury in rats

Intestinal barrier dysfunction often exists in the heat stroke (HS) pathological process, which increases intestinal permeability and induces endotoxemia. The upregulation of MLCK is a crucial player affecting intestinal permeability. This study aimed to explore whether inhibiting myosin light chain kinase (MLCK) can improve HS-induced intestinal injury in rats. Twelve-week-old Wistar male rats were divided into three groups: the control group, the HS model group, and the treatment group [HS model + ML-7 (MLCK inhibitor)]. HS impaired the tight junctions in the rat gut and increased permeability. Additionally, increased inflammatory factors in serum, activation of apoptosis, and downregulation of tight junction proteins were observed in intestinal cells. ML-7 significantly inhibited the MLCK/p-MLC2 signaling pathway, increased the expression of tight junction pro-teins, reduced intestinal permeability, reduced apoptosis and alleviated the intestinal damage caused by HS. ML -7 inhibited HS-induced apoptosis of intestinal epithelial cells by regulating the ERK/p38/HSP70 axis. Further-more, inhibition of MLCK upregulated HSP70 expression through activation of the ERK pathway and inhibited cell apoptosis by abolishing the p38 MAPK pathway. In conclusion, inhibiting the MLCK/p-MLC2 signaling pathway reduces HS-induced intestinal permeability and protects the intestinal mucosal barrier.

Automated summary

Inhibiting myosin light chain kinase (MLCK) can improve heat stroke-induced intestinal injury in rats by reducing intestinal permeability and protecting the intestinal mucosal barrier. This study demonstrates that inhibiting the MLCK/p-MLC2 signaling pathway may serve as a novel therapeutic approach for heat stroke-induced intestinal damage.